enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Eye care professional - Wikipedia

   en.wikipedia.org/wiki/Eye_care_professional

   Ophthalmology (/ˌɒfθælˈmɒlədʒi/ OFF-thal-MOL-ə-jee) is a surgical subspecialty within medicine that handles the diagnosis and treatment of eye disorders.[1] [2] Ophthalmologists are physicians (M.D./D.O/have a doctorate in medicine) that undergo subspecialty training in medical and surgical eye care. [3]

3. Masayo Takahashi - Wikipedia

   en.wikipedia.org/wiki/Masayo_Takahashi

   Masayo Takahashi (高橋 政代, Takahashi Masayo, born June 23, 1961) is a Japanese medical physician, ophthalmologist and stem cell researcher.. Takahashi serves as a project research leader at the Riken Center for Developmental Biology in Kobe focusing on the clinical application of iPS Cell (induced Pluripotent Stem Cell) technology on macular degeneration.

4. Richard F. Spaide - Wikipedia

   en.wikipedia.org/wiki/Richard_F._Spaide

   "Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration [50]" Authors: Richard F Spaide, Ketan Laud, Howard F Fine, JR JAMES M KLANCNIK, Catherine B Meyerle, Lawrence A Yannuzzi, John Sorenson, Jason Slakter, Yale L Fisher, Michael J Cooney, Retina 26 (4), 383-390, 2006.

5. ACT Treats First Patient with Better Vision in Clinical Trial ...

   www.aol.com/2013/04/15/act-treats-first-patient...

   ACT Treats First Patient with Better Vision in Clinical Trial for Stargardt's Macular Dystrophy Patient Injected with 100,000 human embryonic stem cell-(hESC) derived Retinal Pigment Epithelial ...

6. Stem cell therapy for macular degeneration - Wikipedia

   en.wikipedia.org/wiki/Stem_cell_therapy_for...

   Induced pluripotent stem cell taken from blood cell and converted in retinal pigment epithelium. Stem cell therapy for macular degeneration is an emerging treatment approach aimed at restoring vision in individuals suffering from various forms of macular degeneration, particularly age-related macular degeneration (AMD). [1]

7. Anti-VEGF - Wikipedia

   en.wikipedia.org/wiki/Anti-VEGF

   This is done in the treatment of certain cancers and in age-related macular degeneration. They can involve monoclonal antibodies such as bevacizumab , antibody derivatives such as ranibizumab (Lucentis), or orally-available small molecules that inhibit the tyrosine kinases stimulated by VEGF: sunitinib , sorafenib , axitinib , and pazopanib ...